7-74097072-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002314.4(LIMK1):​c.292-8C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,600,782 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 41 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 25 hom. )

Consequence

LIMK1
NM_002314.4 splice_region, intron

Scores

2
Splicing: ADA: 0.001296
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.60
Variant links:
Genes affected
LIMK1 (HGNC:6613): (LIM domain kinase 1) There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-74097072-C-G is Benign according to our data. Variant chr7-74097072-C-G is described in ClinVar as [Benign]. Clinvar id is 709429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0103 (1574/152272) while in subpopulation AFR AF = 0.0367 (1527/41560). AF 95% confidence interval is 0.0352. There are 41 homozygotes in GnomAd4. There are 755 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1574 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIMK1NM_002314.4 linkc.292-8C>G splice_region_variant, intron_variant Intron 3 of 15 ENST00000336180.7 NP_002305.1 P53667-1
LIMK1NM_001204426.2 linkc.190-8C>G splice_region_variant, intron_variant Intron 2 of 14 NP_001191355.1 P53667-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIMK1ENST00000336180.7 linkc.292-8C>G splice_region_variant, intron_variant Intron 3 of 15 1 NM_002314.4 ENSP00000336740.2 P53667-1

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1575
AN:
152154
Hom.:
40
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0369
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00263
AC:
647
AN:
245692
AF XY:
0.00201
show subpopulations
Gnomad AFR exome
AF:
0.0371
Gnomad AMR exome
AF:
0.00114
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000906
Gnomad OTH exome
AF:
0.000830
GnomAD4 exome
AF:
0.00101
AC:
1462
AN:
1448510
Hom.:
25
Cov.:
29
AF XY:
0.000900
AC XY:
649
AN XY:
720810
show subpopulations
Gnomad4 AFR exome
AF:
0.0387
AC:
1290
AN:
33298
Gnomad4 AMR exome
AF:
0.00122
AC:
54
AN:
44356
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
25670
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39622
Gnomad4 SAS exome
AF:
0.000153
AC:
13
AN:
85194
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
53124
Gnomad4 NFE exome
AF:
0.00000545
AC:
6
AN:
1101712
Gnomad4 Remaining exome
AF:
0.00162
AC:
97
AN:
59864
Heterozygous variant carriers
0
73
146
219
292
365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1574
AN:
152272
Hom.:
41
Cov.:
32
AF XY:
0.0101
AC XY:
755
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.0367
AC:
0.0367421
AN:
0.0367421
Gnomad4 AMR
AF:
0.00229
AC:
0.00229088
AN:
0.00229088
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000622
AC:
0.000621891
AN:
0.000621891
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000294
AC:
0.0000294057
AN:
0.0000294057
Gnomad4 OTH
AF:
0.00331
AC:
0.00330813
AN:
0.00330813
Heterozygous variant carriers
0
78
157
235
314
392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000815
Hom.:
1
Bravo
AF:
0.0115
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LIMK1-related disorder Benign:1
Jun 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.45
DANN
Benign
0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.064
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116341069; hg19: chr7-73511402; API